Saizen in Intra-uterine Growth Retardation

NCT01400698 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

91

Enrollment

INDUSTRY

Sponsor class

Conditions

Children Born With Serious Intra-uterine Growth Retardation

Interventions

DRUG: Saizen® A
DRUG: Saizen® B
OTHER: Observation only

Sponsor

Merck KGaA, Darmstadt, Germany

Collaborators

[object Object]